Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Bristol AMR project granted £1.5m
Cows
The project will examine how the wider population is exposed to bacteria from dairy cattle.

Aims to boost understanding of drug resistant bacteria from cattle

A grant of £1.5 million has been awarded to researchers at The University of Bristol to carry out research on drug resistant infections.


Awarded as part of the ‘AMR in the Real World Programme,’ the money will be used to test if AMR bacteria from cattle can cause drug resistant infections in humans.


Project leader, Dr Matthew Avison, explains: “There is little doubt that over-using antibiotics in farm animals and pets increases the number of AMR bacteria in those animals, just as it does in humans. There is also strong evidence that AMR bacteria present in farm animals can spread to humans having close physical contact with them (e.g. farm workers).

“However, there is considerable debate about the extent that AMR bacteria can spread more widely – for example when people eat food contaminated with bacteria from animals or interact with environments contaminated with animal wastes. Our research project will add much needed data to the debate.”

The project will examine how the wider population is exposed to bacteria from dairy cattle, for example while walking on public footpaths.

The researchers also seek to determine the effect of antibiotic use in humans, and what happens when that antibiotic use is reduced.

Professor Alastair Hay, a GP and professor of primary care in the University of Bristol’s School of Social and Community Medicine said: “The recent and very welcome news that the use of antibiotics by GPs and nurses in primary care is reducing provides a ‘natural experiment’.

“We will look to see if these reductions in antibiotic prescribing are translating into reduced rates of antibiotic resistant urine infections. Urine infections are the most common bacterial infection, and the most common antibiotic resistant infection treated by the NHS.

“If we find that a reduction in antibiotic prescribing has led to a reduction in the number of antibiotic resistant urine infections, it will be positive news for patients, GPs and nurses in primary care – suggesting they are ‘on the right track’.”

The ‘AMR in the Real World Programme’ is a cross-council initiative that is currently focusing on resistant bacteria of humans and animals.


It was created following the government’s Five Year Antimicrobial Resistance Strategy (2013-2018) that sets out the actions and research needed to tackle AMR.


Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.